These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Neuronal Adenosine A2A Receptors Are Critical Mediators of Neurodegeneration Triggered by Convulsions. Canas PM; Porciúncula LO; Simões AP; Augusto E; Silva HB; Machado NJ; Gonçalves N; Alfaro TM; Gonçalves FQ; Araújo IM; Real JI; Coelho JE; Andrade GM; Almeida RD; Chen JF; Köfalvi A; Agostinho P; Cunha RA eNeuro; 2018; 5(6):. PubMed ID: 30627646 [TBL] [Abstract][Full Text] [Related]
3. Neuroprotection by caffeine in the MPTP model of parkinson's disease and its dependence on adenosine A2A receptors. Xu K; Di Luca DG; Orrú M; Xu Y; Chen JF; Schwarzschild MA Neuroscience; 2016 May; 322():129-37. PubMed ID: 26905951 [TBL] [Abstract][Full Text] [Related]
4. Differential α-synuclein expression contributes to selective vulnerability of hippocampal neuron subpopulations to fibril-induced toxicity. Luna E; Decker SC; Riddle DM; Caputo A; Zhang B; Cole T; Caswell C; Xie SX; Lee VMY; Luk KC Acta Neuropathol; 2018 Jun; 135(6):855-875. PubMed ID: 29502200 [TBL] [Abstract][Full Text] [Related]
5. Aberrant adenosine A2A receptor signaling contributes to neurodegeneration and cognitive impairments in a mouse model of synucleinopathy. Hu Q; Ren X; Liu Y; Li Z; Zhang L; Chen X; He C; Chen JF Exp Neurol; 2016 Sep; 283(Pt A):213-23. PubMed ID: 27342081 [TBL] [Abstract][Full Text] [Related]
6. The protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro. Dulovic M; Jovanovic M; Xilouri M; Stefanis L; Harhaji-Trajkovic L; Kravic-Stevovic T; Paunovic V; Ardah MT; El-Agnaf OM; Kostic V; Markovic I; Trajkovic V Neurobiol Dis; 2014 Mar; 63():1-11. PubMed ID: 24269733 [TBL] [Abstract][Full Text] [Related]
7. Systematic comparison of the effects of alpha-synuclein mutations on its oligomerization and aggregation. Lázaro DF; Rodrigues EF; Langohr R; Shahpasandzadeh H; Ribeiro T; Guerreiro P; Gerhardt E; Kröhnert K; Klucken J; Pereira MD; Popova B; Kruse N; Mollenhauer B; Rizzoli SO; Braus GH; Danzer KM; Outeiro TF PLoS Genet; 2014 Nov; 10(11):e1004741. PubMed ID: 25393002 [TBL] [Abstract][Full Text] [Related]
10. Alpha synuclein dimers and oligomers are increased in overexpressing conditions in vitro and in vivo. Marmolino D; Foerch P; Atienzar FA; Staelens L; Michel A; Scheller D Mol Cell Neurosci; 2016 Mar; 71():92-101. PubMed ID: 26711807 [TBL] [Abstract][Full Text] [Related]
11. Adenosine A Franco R; Rivas-Santisteban R; Casanovas M; Lillo A; Saura CA; Navarro G Cells; 2020 Apr; 9(5):. PubMed ID: 32357548 [TBL] [Abstract][Full Text] [Related]
12. A Kjaergaard J; Hatfield S; Jones G; Ohta A; Sitkovsky M J Immunol; 2018 Jul; 201(2):782-791. PubMed ID: 29802128 [TBL] [Abstract][Full Text] [Related]
13. Transgenic Mice Expressing Human α-Synuclein in Noradrenergic Neurons Develop Locus Ceruleus Pathology and Nonmotor Features of Parkinson's Disease. Butkovich LM; Houser MC; Chalermpalanupap T; Porter-Stransky KA; Iannitelli AF; Boles JS; Lloyd GM; Coomes AS; Eidson LN; De Sousa Rodrigues ME; Oliver DL; Kelly SD; Chang J; Bengoa-Vergniory N; Wade-Martins R; Giasson BI; Joers V; Weinshenker D; Tansey MG J Neurosci; 2020 Sep; 40(39):7559-7576. PubMed ID: 32868457 [TBL] [Abstract][Full Text] [Related]
14. Adenosine A2A receptor gene disruption protects in an α-synuclein model of Parkinson's disease. Kachroo A; Schwarzschild MA Ann Neurol; 2012 Feb; 71(2):278-82. PubMed ID: 22367999 [TBL] [Abstract][Full Text] [Related]
15. Caspase-1 causes truncation and aggregation of the Parkinson's disease-associated protein α-synuclein. Wang W; Nguyen LT; Burlak C; Chegini F; Guo F; Chataway T; Ju S; Fisher OS; Miller DW; Datta D; Wu F; Wu CX; Landeru A; Wells JA; Cookson MR; Boxer MB; Thomas CJ; Gai WP; Ringe D; Petsko GA; Hoang QQ Proc Natl Acad Sci U S A; 2016 Aug; 113(34):9587-92. PubMed ID: 27482083 [TBL] [Abstract][Full Text] [Related]
16. Blockade of adenosine A Li XC; Hong FF; Tu YJ; Li YA; Ma CY; Yu CY; Fang L; Chen JY; Li ZL; Bao SJ; Zhang ZL; Ying HY; Gyabaah AT; Hu SY; Shao GH; Cai XH Exp Neurol; 2022 Apr; 350():113929. PubMed ID: 34813840 [TBL] [Abstract][Full Text] [Related]
17. The effects of the novel A53E alpha-synuclein mutation on its oligomerization and aggregation. Lázaro DF; Dias MC; Carija A; Navarro S; Madaleno CS; Tenreiro S; Ventura S; Outeiro TF Acta Neuropathol Commun; 2016 Dec; 4(1):128. PubMed ID: 27938414 [TBL] [Abstract][Full Text] [Related]
18. Prolyl oligopeptidase inhibition attenuates the toxicity of a proteasomal inhibitor, lactacystin, in the alpha-synuclein overexpressing cell culture. Myöhänen TT; Norrbacka S; Savolainen MH Neurosci Lett; 2017 Jan; 636():83-89. PubMed ID: 27818354 [TBL] [Abstract][Full Text] [Related]
19. Effects of impaired membrane interactions on α-synuclein aggregation and neurotoxicity. Ysselstein D; Joshi M; Mishra V; Griggs AM; Asiago JM; McCabe GP; Stanciu LA; Post CB; Rochet JC Neurobiol Dis; 2015 Jul; 79():150-63. PubMed ID: 25931201 [TBL] [Abstract][Full Text] [Related]